Meanwhile, CD14+ cells from the same patients at advanced HCC stages acquired PD-L1 and PD-L2 expression and exhibited a IL-12−IL-10+CCL17−CCL1+CXCL13− phenotype (considered a M2bMφ phenotype). This evidence concerns the gene CD14 and hepatocellular carcinoma.